Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)DivestmentsFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BrightSpring Health Services (BTSG) Change in Cash (2023 - 2026)

BrightSpring Health Services posted quarterly Change in Cash of $800.3 million for Q1 2026, up 9394.16% year-on-year from $8.4 million in Q1 2025, and up 1615.1% on a QoQ basis from -$52.8 million in Q4 2025.

BrightSpring Health Services (BTSG) has 4 years of Change in Cash data on file, last reported at $800.3 million in Q1 2026.

  • For the quarter ending Q1 2026, Change in Cash rose 9394.16% year-over-year to $800.3 million; the trailing twelve-month figure through Mar 2026 stood at $836.2 million (up 15598.7% YoY), and the FY2025 full-year result was $27.2 million, down 43.5% from the prior year.
  • Change in Cash for Q1 2026 stood at $800.3 million, up from -$52.8 million in the prior quarter.
  • Across five years, Change in Cash topped out at $800.3 million in Q1 2026 and bottomed at -$52.8 million in Q4 2025.
  • The 4-year median for Change in Cash is $1.4 million (2023), against an average of $67.3 million.
  • The widest annual swing landed in 2024, when Change in Cash plunged 43534.21%; it then jumped 9394.16% in 2026.
  • A 4-year view of Change in Cash shows it stood at $1.4 million in 2023, then surged by 1667.83% to $25.3 million in 2024, then sank by 308.95% to -$52.8 million in 2025, then soared by 1615.1% to $800.3 million in 2026.
  • The last three Change in Cash figures came in at $800.3 million (Q1 2026), -$52.8 million (Q4 2025), and $71.1 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Cash (Qtr)
1 Veeva Systems 30.85 Bn 24.28 Bn 622.47 Mn -238.90 Mn
2 BrightSpring Health Services 12.29 Bn 11.41 Bn 482.22 Mn 800.32 Mn
3 Healthequity 7.80 Bn 7.48 Bn 256.31 Mn -53.56 Mn
4 Hinge Health 4.82 Bn 4.51 Bn 154.23 Mn -21.68 Mn
5 Doximity 4.21 Bn 3.46 Bn 125.97 Mn 154.34 Mn
6 Waystar Holding 4.18 Bn 4.03 Bn 268.04 Mn -14.11 Mn
7 10x Genomics 3.78 Bn 3.24 Bn 106.18 Mn 16.32 Mn
8 Privia Health 2.65 Bn 2.28 Bn 595.71 Mn -60.16 Mn
9 Omnicell 1.95 Bn 1.78 Bn 140.36 Mn 39.93 Mn
10 Teladoc Health 1.42 Bn 672.39 Mn 562.57 Mn -29.46 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 800.32 Mn
Dec 31, 2025 -52.82 Mn
Sep 30, 2025 71.07 Mn
Jun 30, 2025 17.59 Mn
Mar 31, 2025 -8.61 Mn
Dec 31, 2024 25.28 Mn
Sep 30, 2024 10.95 Mn
Jun 30, 2024 -33.01 Mn
Mar 31, 2024 44.97 Mn
Dec 31, 2023 1.43 Mn
Sep 30, 2023 385,000.00
Jun 30, 2023 76,000.00
Mar 31, 2023 -2.45 Mn